Tirzepatide Shows Significant Weight Loss in Obesity: 12-Month Study | Retatrutide News

Tirzepatide led to significant weight loss over 12 months in people with obesity or overweight. This supports the potential of GLP-1 agonists like Retat...
Weight Loss · October 29, 2026